Cardiovascular Pharmacologists analyze how various drugs influence the function and structure of the heart and blood vessels. They work to develop, refine, and assess medications that treat a range of cardiovascular conditions such as high blood pressure, heart failure, arrhythmias, and coronary artery disease. These professionals explore drug mechanisms, evaluate therapeutic effects, and identify potential side effects, helping ensure that treatments are both safe and effective. Their research spans cellular responses, biochemical pathways, and how medications interact with cardiovascular tissues to bring about desired outcomes.
Their work is critical in both laboratory and clinical environments, where they collaborate with physicians, researchers, and drug developers to test new compounds and improve existing therapies. Cardiovascular pharmacologists use data from experimental models, patient studies, and clinical trials to understand how drugs behave in the body and how they can be optimized for individual care. Their findings directly influence medical guidelines and prescribing practices, ensuring evidence-based approaches in treatment. They are also instrumental in addressing challenges like drug resistance or adverse cardiovascular reactions. By advancing the science behind medication use, they contribute to more precise and targeted therapies that support long-term heart health. Through their expertise, they continue to shape the landscape of heart disease prevention and management worldwide.
Title : Preservation of Skeletal Muscle Mass During GLP 1 Receptor Agonist Mediated Weight Loss Clinical Determinants Risk Stratification and Evidence Based Mitigation Strategies
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : CARDIAC TROPONIN AND HOMOCYSTEINE LEVELS IN HEMODIALYSIS PATIENTS: ASSOCIATION WITH DIALYSIS VINTAGE AND CARDIOVASCULAR COMORBIDITY
Sofra Maria, Aretaieion University Hospital, Greece
Title : Finite-Element and Electromagnetic Cardio-Vascular Simulation for Drug Testing, Monitoring, and Safety Projection Using Bansal B–Bio Framework
Abhishek Bansal, New Era Consultancy Services, India
Title : Lipid and High-Density Lipoprotein (HDL) Subfraction Changes in Premenopausal and Postmenopausal Women with Breast Cancer Receiving Hormonal Therapy
Sofra Maria, Aretaieion University Hospital, Greece
Title : Sex-Specific Metabolic Reprogramming by Nanoemulsified Policosanol-Simvastatin Combinations: Synergistic Regulation of the IIS Pathway and BMM-Mediated Lipolysis in a Drosophila Model of Metabolic Syndrome
Lawal Kayode Olatunji, Usmanu Danfodiyo University Sokoto, Nigeria
Title : Intact Right Sinus of Valsalva Aneurysm Dissecting the Interventricular Septum: A Rare Cause of Complete Heart Block in Post-Mitral Valve Replacement
Keval Ajay Shah, APOLLO HOSPITAL NAVI MUMBAI, India